CStone Pharmaceuticals
Juan Zhang is an accomplished professional in pharmacology, currently serving as Vice President at 基石药业 since December 2016. Prior to this role, Juan Zhang held various leadership positions at CrownBio Science from October 2008 to December 2016, progressing from Associate Director to Director and finally to Sr. Director. With over a decade of experience in the industry, Juan Zhang has demonstrated expertise in advancing pharmacological research and development.
This person is not in any offices
CStone Pharmaceuticals
CStone is a biopharmaceutical company focused on developing and commercializing innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established at the end of 2015, CStone has assembled a world-class management team with extensive experience in innovative drug development, clinical research, and commercialization. With a strategic emphasis on immuno-oncology combination therapies, the Company has built an oncology-focused pipeline of 16 drug candidates, including 5 late-stage candidates at pivotal trials or registration stages. With an experienced team, a rich pipeline, a robust clinical development-driven business model and substantial funding, CStone’s vision is to become a world-renowned biopharmaceutical company that is leading the way to conquering cancer.